Cheri Levinson

190 Followers
180 Following
669 Posts
Assoc Prof & Director of Eating Anxiety Treatment (EAT) lab @UofL, I build new #treatments for #eatingdisorders, fighting back against #dietculture #weightstigma to save lives, mom of 2 girls, yogatt200
RT @irene_xu_mengye
HALF of trans and non-binary youth have considered suicide in the past year. 20% have attempted suicide. Yet 50% doesn’t find it safe to disclose their struggles and 70% find support online. TP’s visuals are incredible in disseminating this important & heartbreaking data https://twitter.com/trevorproject/status/1653006352153755650
The Trevor Project on Twitter

“NEW: At a time when LGBTQ existence is unfairly at the center of national political debate, our 2023 National Survey shows the urgency of ensuring that LGBTQ young people feel safe, supported & belonged. Building a better world for LGBTQ youth starts with you. Read our survey ⬇️”

Twitter
Thank you @v_solesmith - I’m only on the introduction & feel these words deep in my soul
RT @CRalphNearman
Super excited for this paper to come out soon in Behavior Therapy testing the theory of #clinical #perfectionism in #eatingdisorders A huge shoutout to my amazing & lovely co-authors @psychbren @amlortiz @CheriLev 🎉🎉 @uofl https://twitter.com/uofleatlab/status/1653832722408677379
EAT Lab on Twitter

“Another paper accepted to Behavior Therapy! Congrats @CRalphNearman and team for their paper about clinical perfectionism in a transdiagnostic ED sample. We're excited for it to come out!”

Twitter

RT @HealthBegins
Discrimination for #obesity is rampant in the medical community. #SDOH

‘There’s a huge fatphobia problem in the eating disorder world’ Even in treatment, weight stigma fails patients https://buff.ly/3HbWEoU by @_gaffknee via @statnews CC: @theshirarose @CheriLev @ColleenSchreyer

'There's a huge fatphobia problem in the eating disorder world': Even in treatment, weight stigma fails patients

Eating disorder specialists disagree about how to best address obesity and weight stigma — a conflict that may leave patients susceptible to inappropriate or harmful care.

STAT

RT @deirdre_tobias
Meta-analysis of meta-analyses of RCTs:

dietary interventions to modify macronutrient composition still irrelevant for weight loss in patients with type 2 diabetes.

No more low-carb vs. low-fat weight loss trials. It’s over. No difference. Move on.

https://link.springer.com/article/10.1007/s00125-021-05577-2

Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission - Diabetologia

Aims/hypothesis Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials, up to 10 May 2021. Findings were synthesised by diet type and study quality (Cochrane Risk of Bias tool 2.0 and Risk Of Bias In Non-randomised Studies – of Interventions [ROBINS-I]), with GRADE applied (PROSPERO CRD42020208878). Results We identified 19 meta-analyses of weight-loss diets, involving 2–23 primary trials (n = 100–1587), published 2013–2021. Twelve were ‘critically low’ or ‘low’ AMSTAR 2 quality, with seven ‘high’ quality. Greatest weight loss was reported with very low energy diets, 1.7–2.1 MJ/day (400–500 kcal) for 8–12 weeks (high-quality meta-analysis, GRADE low), achieving 6.6 kg (95% CI −9.5, −3.7) greater weight loss than low-energy diets (4.2–6.3 MJ/day [1000–1500 kcal]). Formula meal replacements (high quality, GRADE moderate) achieved 2.4 kg (95% CI −3.3, −1.4) greater weight loss over 12–52 weeks. Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate). For type 2 diabetes remission, of 373 records, 16 met inclusion criteria. Remissions at 1 year were reported for a median 54% of participants in RCTs including initial low-energy total diet replacement (low-risk-of-bias study, GRADE high), and 11% and 15% for meal replacements and Mediterranean diets, respectively (some concerns for risk of bias in studies, GRADE moderate/low). For ketogenic/very low-carbohydrate and very low-energy food-based diets, the evidence for remission (20% and 22%, respectively) has serious and critical risk of bias, and GRADE certainty is very low. Conclusions/interpretation Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets. Programmes including a hypocaloric formula ‘total diet replacement’ induction phase were most effective for type 2 diabetes remission. Most of the evidence is restricted to 1 year or less. Well-conducted research is needed to assess longer-term impacts on weight, glycaemic control, clinical outcomes and diabetes complications. Graphical abstract

SpringerLink
RT @Debsliztaylor
1/1 … Having recently lost my beautiful 24 year old daughter to anorexia, I know that her untimely death could have been prevented if waiting lists were not so prevelant. Timely treatment with robust evidence based training for clinicians can and does prevent deaths.
RT @jacasiegel
Please share in your networks! ✨
We're recruiting participants for our new study on weight stigma in casual sexual experiences among sexual minority men. Please see more information in the advertisement below. Please contact Connor with questions or to express interest! Thanks!
RT @uofleatlab
We have expanded the criteria for our Online Relapse Prevention Study! Participate in a new PAID study with the EAT Laboratory. Join a clinical trial comparing two 5-week online #eatingdisorder relapse prevention treatments! More information here: https://www.louisvilleeatlab.com/online-relapse-prevention-study.html
Online Relapse Prevention Study

sAbout the Study Help us create an evidence-based relapse prevention program and get free treatment! The purpose of this clinical trial is to compare two five-week online eating disorder relapse...

EAT LAB
RT @CRalphNearman
@UofLInnovate @uofl @CheriLev @LARRIUofL @UofLSpeedEng @UofLMedicine Such an HONOR to be presented an #Innovation & #Entrepreneurship #Trailblazer award! Very proud of our @uofleatlab team’s work building therapeutics toward extinguishing #eatingdisorders Also that @CheriLev & I were the 2 women to be honored with awards❤️ #GoCards #STEM #Awaken

RT @CMPinciotti
🎉We’re hiring!🎉 Come work with me as research coordinator on youth suicide prevention, and get involved with lots of incredible research happening in the Storch lab at Baylor College of Medicine! Perfect for anyone wanting more experience with research:

https://jobs.bcm.edu/job/Houston-Research-Coordinator-II-Texa/1013746800/

Research Coordinator II

Research Coordinator II